Renaissance IPO ETF (IPO) |
| 43.53 -1.802 (-3.98%) 02-27 16:00 |
| Open: | 43.76 |
| High: | 43.94 |
| Low: | 43.13 |
| Volume: | 21,454 |
| Market Cap: | 127(M) |
| PE Ratio: | 30.51 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 48.62 |
| Resistance 1: | 45.91 |
| Pivot price: | 44.25 |
| Support 1: | 41.53 |
| Support 2: | 34.55 |
| 52w High: | 54.68 |
| 52w Low: | 31.2 |
The fund seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the index. It normally invests at least 80% of its total assets in securities that comprise the index. The index is a portfolio of companies that have recently completed an initial public offering ("IPO") and are listed on a U.S. exchange. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 27 Feb 2026
U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market - Seeking Alpha
Fri, 27 Feb 2026
IPO News - US IPO Week Ahead: Medtronic carve-out MiniMed to kick-off March calendar - renaissancecapital.com
Fri, 27 Feb 2026
IPO News - US IPO Weekly Recap: Asthma-focused Generate Biomedicines closes out February IPO market - renaissancecapital.com
Thu, 26 Feb 2026
Bookstore chains Barnes & Noble and Waterstones are one step closer to an IPO - Seeking Alpha
Tue, 24 Feb 2026
How to Invest in the Renaissance IPO ETF (IPO) - The Motley Fool
Sat, 21 Feb 2026
IPO News - International IPO Weekly Winners & Losers - renaissancecapital.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
